)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
AngioDynamics (ANGO) investor relations material
AngioDynamics UBS Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.UBS Global Healthcare Conference 2025 summary10 Nov, 2025
Transformation and business strategy
Underwent a major transformation over the past five years, shifting from a broad device portfolio to a focused MedTech company targeting high-growth, high-margin markets.
MedTech segment now represents about 45% of revenue, up from less than 17% five years ago, and is expected to become the largest segment next fiscal year.
Med device segment provides stable cash flow and EBITDA, funding MedTech growth but is not a focus for future investment.
No debt and a strong balance sheet, with plans to be cash flow positive this fiscal year and beyond.
Capital allocation will prioritize internal innovation and data generation over M&A for the next three to five years.
MedTech segment growth and market opportunities
MedTech segment has achieved a 25% CAGR over the last five years, driven by platform technologies with potential for further market expansion.
Key platforms: NanoKnife (interventional oncology), Arion (PAD), and AlphaVac/AngioVac (VTE/thrombus management).
NanoKnife received a new label for intermediate-risk prostate cancer, opening a $2B+ global market; CPT1 code approved in January.
Arion system has grown from zero to $60M+ in revenue since 2020, now #3 in the PAD market, with hospital sales nearing parity with OBL.
AlphaVac and AngioVac products are taking share in the $3B U.S. PE market, with mechanical thrombectomy business expected to grow from $40M to $50M this year.
Market dynamics, clinical evidence, and innovation
Mechanical thrombectomy market is expanding due to increased clinical evidence and physician confidence, with a focus on data generation and market development.
Pricing in both thrombectomy and PAD markets has stabilized, with potential slight tailwinds from reimbursement changes.
Ambition BTK study aims to demonstrate safety and efficacy of atherectomy below the knee, supporting further adoption and reducing amputations.
Early diagnosis and awareness are key to increasing intervention rates and improving patient outcomes in PAD and prostate cancer.
Innovation strategy centers on leveraging existing platforms for new indications and markets, with minimal additional R&D required.
NanoKnife: BPH market opportunity and timeline?
Auryon's sustained share gains vs. larger competitors
Medical Device segment: long-term strategic role?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AngioDynamics earnings date
Q2 20267 Jan, 2026
Next AngioDynamics earnings date
Q2 20267 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for use by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings in the United States and internationally. The company operates through four segments: Vascular Access, Peripheral Vascular, Oncology/Surgery, and Venous Therapies. The Peripheral Vascular segment primarily offers radiofrequency ablation systems to ablate or destroy undesired tissue; angiographic products to access the vasculature; thrombolytic products to treat clots; embolization products to block blood flow to a tumor; vena cava filters to trap clot before it can travel to the lungs; dialysis catheters used in hemodialysis procedures; and a range of products used in minimally-invasive, image-guided procedures.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage